Journal of Molecular Histology & Medical Physiology

ISSN: 2684-494X

Open Access

Evron Eitan

Department of Biology, Kaplan Medical Institute, The Hebrew University, Jerusalem 9190501, Israel

  • Mini Review   
    Female Carriers of Germline Pathogenic
    Author(s): Evron Eitan*

    Females with germline BRCA1/BRCA2 (BRCA) P/LPV are given a tight surveillance programme from the ages of 25 to 30 that includes risk-reduction interventions and aims to detect certain cancer types early. Numerous national and international surveillance standards have been created and updated over the past 20 years by a wide range of countries from all over the world. Between January 1, 2015 and May 1, 2022, we searched for regulations that had been published. A few notable examples include variations in primary prevention recommendations, mammography screening in young (30 years) carriers, MRI screening in carriers older than 65 years, any breast imaging after a risk-reducing bilateral mastectomy, while pregnant or nursing and hormone replacement therapy. Beyond official advice, BRCA carriers' concerns also centre on fertility preservation, the management of me.. Read More»
    DOI: 10.37421/2684-494X.2022.7.43

    Abstract HTML PDF

arrow_upward arrow_upward